Publications by authors named "Achim Rittmeyer"

29Publications

Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).

Authors:
Frank Griesinger Wilfried Eberhardt Arnd Nusch Marcel Reiser Mark-Oliver Zahn Christoph Maintz Christiane Bernhardt Christoph Losem Albrecht Stenzinger Lukas C Heukamp Reinhard Büttner Norbert Marschner Martina Jänicke Annette Fleitz Lisa Spring Jörg Sahlmann Aysun Karatas Annette Hipper Wilko Weichert Monika Heilmann Parvis Sadjadian Wolfgang Gleiber Christian Grah Cornelius F Waller Martin Reck Achim Rittmeyer Petros Christopoulos Martin Sebastian Michael Thomas

Lung Cancer 2020 Nov 2. Epub 2020 Nov 2.

Onkologie der Thoraxtumore, Thoraxklinik Heidelberg gGmbH, German Center for Lung Research (DZL), Germany.

View Article and Find Full Text PDF
November 2020

Atezolizumab Versus Docetaxel in Pretreated Patients With NSCLC: Final Results From the Randomized Phase 2 POPLAR and Phase 3 OAK Clinical Trials.

Authors:
Julien Mazieres Achim Rittmeyer Shirish Gadgeel Toyoaki Hida David R Gandara Diego L Cortinovis Fabrice Barlesi Wei Yu Christina Matheny Marcus Ballinger Keunchil Park

J Thorac Oncol 2021 Jan 6;16(1):140-150. Epub 2020 Nov 6.

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article and Find Full Text PDF
January 2021

Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy.

Authors:
Thomas Iseli Thierry Berghmans Markus Glatzer Achim Rittmeyer Gilbert Massard Valérie Durieux Thomas Buchsbaum Paul Martin Putora

ERJ Open Res 2020 Jul 14;6(3). Epub 2020 Sep 14.

Dept of Radiation Oncology, Kantonsspital St Gallen, St Gallen, Switzerland.

View Article and Find Full Text PDF
July 2020

Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV.

Authors:
Wolfgang M Brueckl Martin Reck Achim Rittmeyer Jens Kollmeier Claas Wesseler Gunther H Wiest Petros Christopoulos Amanda Tufman Petra Hoffknecht Bernhard Ulm Fabian Reich Joachim H Ficker Eckart Laack

Clin Med Insights Oncol 2020 19;14:1179554920951358. Epub 2020 Aug 19.

Hämato-Onkologie Hamburg, Praxis, Hamburg, Germany.

View Article and Find Full Text PDF
August 2020

Top-level gene copy number gain defines a subtype of poorly differentiated pulmonary adenocarcinomas with poor prognosis.

Authors:
Tobias Raphael Overbeck Dana Alina Cron Katja Schmitz Achim Rittmeyer Wolfgang Körber Sara Hugo Juliane Schnalke Laura Lukat Tabea Hugo Marc Hinterthaner Kirsten Reuter-Jessen Tessa Rosenthal Joachim Moecks Annalen Bleckmann Hans-Ulrich Schildhaus

Transl Lung Cancer Res 2020 Jun;9(3):603-616

Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany.

View Article and Find Full Text PDF
June 2020

Abscopal effect in lung cancer: three case reports and a concise review.

Authors:
Elena Garelli Achim Rittmeyer Paul Martin Putora Markus Glatzer Ralf Dressel Stefan Andreas

Immunotherapy 2019 12;11(17):1445-1461

Department of Pneumology & Cardiology, University Medical Center Göttingen, Georg-August University, Göttingen, Germany.

View Article and Find Full Text PDF
December 2019

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial.

Authors:
Howard West Michael McCleod Maen Hussein Alessandro Morabito Achim Rittmeyer Henry J Conter Hans-Georg Kopp Davey Daniel Steven McCune Tarek Mekhail Alona Zer Niels Reinmuth Ahad Sadiq Alan Sandler Wei Lin Tania Ochi Lohmann Venice Archer Lijia Wang Marcin Kowanetz Federico Cappuzzo

Lancet Oncol 2019 07 20;20(7):924-937. Epub 2019 May 20.

Department of Oncology and Hematology, AUSL Romagna, Ravenna, Italy. Electronic address:

View Article and Find Full Text PDF
July 2019

Monitoring efficacy of checkpoint inhibitor therapy in patients with non-small-cell lung cancer.

Authors:
Annett Schiwitza Hans-Ulrich Schildhaus Birgit Zwerger Josef Rüschoff Christian Reinhardt Andreas Leha Stefan Andreas Achim Rittmeyer

Immunotherapy 2019 06;11(9):769-782

LKI Lungenfachklinik Immenhausen, Immenhausen, Germany.

View Article and Find Full Text PDF
June 2019

Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study.

Authors:
Shirish M Gadgeel Rimas V Lukas Jerome Goldschmidt Paul Conkling Keunchil Park Diego Cortinovis Filippo de Marinis Achim Rittmeyer Jyoti D Patel Joachim von Pawel Carol O'Hear Catherine Lai Sylvia Hu Marcus Ballinger Alan Sandler Mayank Gandhi Lou Fehrenbacher

Lung Cancer 2019 02 19;128:105-112. Epub 2018 Dec 19.

Kaiser Permanente Medical Center, 975 Sereno Drive, Vallejo, CA 94589, USA. Electronic address:

View Article and Find Full Text PDF
February 2019

Multidisciplinary treatment of lung cancer in older patients: A review.

Authors:
Marco Radovic Ravindran Kanesvaran Achim Rittmeyer Martin Früh Fabrizio Minervini Markus Glatzer Paul Martin Putora

J Geriatr Oncol 2019 05 3;10(3):405-410. Epub 2018 Oct 3.

Dept of Radiation Oncology, Kantonsspital St Gallen, St Gallen, Switzerland. Electronic address:

View Article and Find Full Text PDF
May 2019

Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study.

Authors:
David R Gandara Joachim von Pawel Julien Mazieres Richard Sullivan Åslaug Helland Ji-Youn Han Santiago Ponce Aix Achim Rittmeyer Fabrice Barlesi Toshio Kubo Keunchil Park Jerome Goldschmidt Mayank Gandhi Cindy Yun Wei Yu Christina Matheny Pei He Alan Sandler Marcus Ballinger Louis Fehrenbacher

J Thorac Oncol 2018 12 11;13(12):1906-1918. Epub 2018 Sep 11.

Kaiser Permanente Medical Center, Vallejo, California.

View Article and Find Full Text PDF
December 2018

Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers.

Authors:
Solange Peters Rolf Stahel Lukas Bubendorf Philip Bonomi Augusto Villegas Dariusz M Kowalski Christina S Baik Dolores Isla Javier De Castro Carpeno Pilar Garrido Achim Rittmeyer Marcello Tiseo Christoph Meyenberg Sanne de Haas Lisa H Lam Michael W Lu Thomas E Stinchcombe

Clin Cancer Res 2019 01 11;25(1):64-72. Epub 2018 Sep 11.

Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina.

View Article and Find Full Text PDF
January 2019

Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab.

Authors:
David R Gandara Sarah M Paul Marcin Kowanetz Erica Schleifman Wei Zou Yan Li Achim Rittmeyer Louis Fehrenbacher Geoff Otto Christine Malboeuf Daniel S Lieber Doron Lipson Jacob Silterra Lukas Amler Todd Riehl Craig A Cummings Priti S Hegde Alan Sandler Marcus Ballinger David Fabrizio Tony Mok David S Shames

Nat Med 2018 09 6;24(9):1441-1448. Epub 2018 Aug 6.

Genentech, Inc., San Francisco, CA, USA.

View Article and Find Full Text PDF
September 2018

Patient-Reported Outcomes in OAK: A Phase III Study of Atezolizumab Versus Docetaxel in Advanced Non-Small-cell Lung Cancer.

Authors:
Rodolfo Bordoni Fortunato Ciardiello Joachim von Pawel Diego Cortinovis Thomas Karagiannis Marcus Ballinger Alan Sandler Wei Yu Pei He Christina Matheny Federico Felizzi Achim Rittmeyer

Clin Lung Cancer 2018 09 31;19(5):441-449.e4. Epub 2018 May 31.

LKI Lungenfachklinik Immenhausen, Immenhausen, Germany.

View Article and Find Full Text PDF
September 2018

Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer.

Authors:
Louis Fehrenbacher Joachim von Pawel Keunchil Park Achim Rittmeyer David R Gandara Santiago Ponce Aix Ji-Youn Han Shirish M Gadgeel Toyoaki Hida Diego L Cortinovis Manuel Cobo Dariusz M Kowalski Filippo De Marinis Mayank Gandhi Bradford Danner Christina Matheny Marcin Kowanetz Pei He Federico Felizzi Hina Patel Alan Sandler Marcus Ballinger Fabrice Barlesi

J Thorac Oncol 2018 08 17;13(8):1156-1170. Epub 2018 May 17.

Aix Marseille University, Assistance Publique Hôpitaux de Marseille, Marseille, France.

View Article and Find Full Text PDF
August 2018

A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non-Small Cell Lung Cancer Based on Early Tumor Kinetics.

Authors:
Laurent Claret Jin Y Jin Charles Ferté Helen Winter Sandhya Girish Mark Stroh Pei He Marcus Ballinger Alan Sandler Amita Joshi Achim Rittmeyer David Gandara Jean-Charles Soria René Bruno

Clin Cancer Res 2018 07 23;24(14):3292-3298. Epub 2018 Apr 23.

Clinical Pharmacology, Roche/Genentech, Marseille, France.

View Article and Find Full Text PDF
July 2018

Treatment of limited disease small cell lung cancer: the multidisciplinary team.

Authors:
Markus Glatzer Achim Rittmeyer Joachim Müller Isabelle Opitz Alexandros Papachristofilou Ioannis Psallidas Martin Früh Diana Born Paul Martin Putora

Eur Respir J 2017 08 24;50(2). Epub 2017 Aug 24.

Dept of Radiation Oncology, Kantonsspital St Gallen, St Gallen, Switzerland.

View Article and Find Full Text PDF
August 2017

Prospects and progress of atezolizumab in non-small cell lung cancer.

Authors:
Johan Vansteenkiste Els Wauters Keunchil Park Achim Rittmeyer Alan Sandler Alexander Spira

Expert Opin Biol Ther 2017 06 28;17(6):781-789. Epub 2017 Mar 28.

e US Oncology Thoracic Oncology Program , Virginia Cancer Specialists , Fairfax , VA 22031.

View Article and Find Full Text PDF
June 2017

Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial.

Authors:
Sylvia Guetz Amanda Tufman Joachim von Pawel Achim Rittmeyer Astrid Borgmeier Pierre Ferré Birgit Edlich Rudolf Maria Huber

Onco Targets Ther 2017 21;10:1081-1089. Epub 2017 Feb 21.

University Hospital Munich and Thoracic Oncology Centre Munich, Member of the German Center for Lung Research, Comprehensive Pneumology Center Munich (DZL CPC-M), Munich.

View Article and Find Full Text PDF
February 2017

[Chemotherapy in the Elderly with Non-Small Cell Lung Cancer: A Non-Interventional, Prospective, Multicentric Observational Study].

Authors:
David Felix Heigener Gert Hoeffken Dieter Wuerflein Matthias Feurer Achim Rittmeyer Roland Maria Huber Markus Pietsch Arne Ring Karl-Matthias Deppermann

Dtsch Med Wochenschr 2017 Feb 24;142(4):e21-e27. Epub 2017 Feb 24.

Sana Krankenhaus Gerresheim, Abteilung Pneumologie, Düsseldorf.

View Article and Find Full Text PDF
February 2017